Positive results for anifrolumab in phase III SLE trial

被引:6
|
作者
Onuora, Sarah
机构
[1] Nature Reviews Rheumatology,
关键词
D O I
10.1038/s41584-020-0384-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:125 / 125
页数:1
相关论文
共 50 条
  • [41] Positive results for rituximab in patients with neuropsychiatric SLE
    Nature Clinical Practice Rheumatology, 2007, 3 (6): : 311 - 312
  • [42] Subgroup analysis of FOCUS phase III trial efficacy results
    Wheater, M.
    Orloff, M.
    Ferrucci, P. F.
    Choi, J.
    Eschelman, D.
    Glazer, E.
    Ejaz, A.
    Richtig, E.
    Ochsenreither, S.
    Reddy, S. A.
    Lowe, M.
    Beasley, G.
    Gesierich, A.
    Gschnell, M.
    Dummer, R.
    Arance, A. M.
    Fenwick, S.
    John, J.
    Ottensmeier, C. H. H.
    Zager, J. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S741 - S742
  • [44] Results of the phase III randomized controlled trial of minocycline in ALS
    Gordon, Paul H.
    Moore, Dan H.
    Florence, Julaine M.
    Verheijde, Joseph L.
    Spitalny, Scottsdale G. Mark
    Doorish, Carolyn
    Santos, Terence
    Miller, Robert G.
    NEUROLOGY, 2007, 68 (12) : A90 - A90
  • [45] Lupus: Phase III Trial Results with Blisibimod is well tolerated
    不详
    NEPHROLOGE, 2016, 11 (01): : 2 - 2
  • [46] Keys for reading the results of a large phase III therapeutic trial
    Milleron, B.
    Besse, B.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2009, 65 : S88 - S93
  • [50] CHARACTERIZATION OF PK/PD OF ANIFROLUMAB IN PATIENTS WITH MODERATE TO SEVERE SLE
    Chia, Y. L.
    Tummala, R.
    Mai, T.
    Rouse, T.
    White, W.
    Morand, E. F.
    Furie, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 590 - 591